Vir Biotechnology, Inc. — Director's Dealing 2019

Oct 11, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2019-10-10

Reporting Person: Parrish Jay (Chief Business Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	222222	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.49	2027-10-05	Common Stock (222221)		Direct
Stock Option (Right to Buy)	$1.58	2028-07-19	Common Stock (111110)		Direct

Footnotes

F1: 1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.

F2: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.